Pri-Med Phoenix

Phoenix, AZ | October 6-7, 2020

Phoenix Convention Center-South Building

Disclosures

The following financial relationships have been disclosed by faculty:  

Financial Disclosures

Peng Thim Fan, MD, FACP
Abbvie, Speakers Bureau; Amgen, Speakers Bureau; Exagen, Advisory Board; Novartis, Speakers Bureau; Pfizer, Speakers Bureau; Radius, Speakers Bureau; Regeneron, Speakers Bureau; Sanofi Genzyme, Speakers Bureau
Pamela Kushner, MD, FAAFP
AstraZeneca, Advisory Board; AstraZeneca, Consultant; AstraZeneca, Speakers Bureau; Bristol-Myers Squibb, Advisory Board; Janssen Pharmaceuticals, Inc., Advisory Board; Janssen Pharmaceuticals, Inc., Consultant; Janssen Pharmaceuticals, Inc., Speakers Bureau; Lilly USA, LLC, Advisory Board; Novo Nordisk Inc., Advisory Board; Pfizer, Advisory Board
Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FTOS
Novo Nordisk Inc, Advisory Board
Jeff Unger, MD, FAAFP, FACE
Abbott Laboratories, Advisory Board; Abbott Laboratories, Contracted Research; Abbott Laboratories, Speakers Bureau; Amgen Inc., Speakers Bureau; GlaxoSmithKline, Contracted Research; Janssen Pharmaceuticals, Inc., Advisory Board; Janssen Pharmaceuticals, Inc., Contracted Research; Janssen Pharmaceuticals, Inc., Speakers Bureau; Novo Nordisk Inc., Advisory Board; Novo Nordisk Inc., Contracted Research; Novo Nordisk Inc., Ownership Interest; Novo Nordisk Inc., Speakers Bureau
Shirah Vollmer, MD
No financial disclosures
Karol E. Watson, MD, PhD
Amarin Pharma Inc., Advisory Board; Amgen, Advisory Board; Boehringer Ingelheim Pharmaceuticals Inc. and Lilly USA, LLC, Speakers Bureau; Boehringer Ingelheim Pharmaceuticals Inc. and Lilly USA, LLC., Advisory Board; Esperion, Advisory Board

Other Disclosures

Pamela Kushner, MD, FAAFP (Reviewer):  Advisory Board and Speaker's Bureau for AstraZeneca, GlaxoSmithKline, and Janssen Pharmaceuticals, Inc.; Consulting Fee and Services Provided for Promotional Purposes for AstraZeneca and Janssen Pharmaceuticals.

All other non-faculty contributors involved in the planning, development, editing and review of the content have disclosed no relevant financial relationships.